🔍 Key Findings

• SVAPs placed in axillary (aSVAP) or femoral/external iliac veins (fSVAP) during limb amputation remained functional in 92.3% and 100% of cases, respectively.
• Complication rates were lower in aSVAP (23.1%) and fSVAP (0%) compared to jSVAP (47.4%), although not statistically significant (P = .12).
• No catastrophic complications occurred with aSVAP or fSVAP; 2 deaths occurred with jSVAP due to port-related issues.
• Infection-related port removal was needed in 1 aSVAP (7.7%) and 2 jSVAPs (10.5%) — no removals were required in fSVAPs.
• Tip placement of the catheter (e.g., right atrium vs. vena cava) did not correlate with complications (P = .66).
• Shorter surgical time likely with aSVAP/fSVAP as they use the same surgical field as the limb amputation.
• Survival time median was similar across groups (jSVAP: 177 days, aSVAP: 125 days, fSVAP: 122 days).
• SVAP implantation during limb amputation offers a practical and safe alternative to separate jugular placement.

🔍 Key Findings

Source: Bush et al., 2023, Veterinary Surgery

• Median survival time (MST) after surgery was 1886 days, which is significantly longer than previously reported.
• Lymph node metastasis at surgery was a negative prognostic factor, reducing MST to 248 days (vs. 2340 days without nodal involvement).
• Local recurrence occurred in 42% of dogs, with a median disease-free interval (DFI) of 191 days.
• Metastatic disease occurred in 32% of dogs, most commonly to the lungs, with a median DFI of 299 days.
• Histologic features (e.g., margin status, capsular, lymphatic, or vascular invasion) were not significantly correlated with recurrence or metastasis.
• Facial nerve injury occurred in 9.7% perioperatively, especially after parotidectomy; intraoperative facial nerve transection led to long-term deficits.
• Adjuvant therapies (chemotherapy, radiation, NSAIDs) did not significantly affect survival time.
• Incisional biopsy was only 38% concordant with final excisional histology, suggesting limited reliability for definitive diagnosis.

🔍 Key Findings Summary

• Used VMBDmD to quantify hip laxity under increasing force in cadaveric dogs (n=34).
• 90% of hips reached ≥90% of LImax at 95.32 N, defining this force as sufficient for subluxation.
• LImax was not significantly influenced by osteoarthritis, weight, sex, or limb side.
• Position of device (lever length) influenced rate of laxity acquisition, not final LImax.
• LI curves were repeatable across 5 sessions, indicating elastic—not plastic—deformation.

🔍 Key Findings

• 67.9% of respondents reported using SSCs, with most indicating frequent use (64% used in every surgery).
• 78.7% agreed SSCs reduce complications, and 89.6% believed SSCs improve communication.
• Respondents not using SSCs were more likely to view them as a waste of time (p < .001).
• Forgetfulness (39.6%) and time constraints (36.5%) were leading reasons for checklist noncompletion.
• Only 23.3% had SSC training during surgical residency, with newer diplomates more likely to have had exposure (p < .001).
• Key strategies to improve uptake included: staff feedback modifications (67.9%), formal designation of initiator (48.6%), and training (52.2%).
• Surgeons and OR staff were most commonly identified as noncompliant team members.
• SSC use was more frequent in small animal practices, and mandating SSCs by management was favored but not always effective alone.

🔍 Key Findings Summary

• Prevalence of contralateral CCLR in dogs ≥8 years and ≥15kg was 19.1%, notably lower than previous studies (33–50%).
• Median time to contralateral CCLR was 12.9 months.
• Older age reduced risk — 2% decrease per month of age (p=0.003).
• Golden Retrievers and Labradors had significantly lower risk (p=0.028 and p=0.007, respectively).
• No effect found from TPA, meniscal injury, or comorbidities (e.g., hip dysplasia, hypothyroidism).

🔍 Key Findings

• A patient-specific dorsal implant for atlantoaxial stabilization was developed using CT-based 3D modeling, enabling customized implant design and safe screw trajectory planning.
• The implant accommodates six 1.7-mm bicortical locking screws, including two transarticular screws plus two screws in each vertebra (atlas lateral masses and axis lamina/spinous base).
• The implant also functions as a drilling guide, allowing the screw-head housing to accept a threaded drill guide that ensures accurate drilling along predefined safe corridors.
• An opening around the C1–C2 intervertebral foramen was incorporated to avoid injury to the C2 nerve root during dorsal instrumentation.
• Finite element analysis evaluated implant behavior under flexion, extension, lateral flexion, and torsion using loads of 50 N (physiologic) and 107 N (supraphysiologic).
• Maximum stress occurred during lateral flexion with axis fixation (425 MPa), which remained well below the titanium alloy yield strength of 880 MPa, indicating no mechanical failure.
• Maximum implant displacement was minimal (0.13 mm), far less than the approximately 2 mm movement of the intact atlantoaxial joint under physiologic loading.
• The implant design demonstrated adequate rigidity and mechanical safety in simulation, suggesting potential to improve dorsal stabilization while avoiding complications associated with PMMA constructs.

🔍 Key Findings

• Exercise-based rehabilitation showed benefits in 6 of 7 studies, including increased peak vertical force (PVF) and reduced lameness, though most had high risk of bias (RoB).
• Cold compression therapy (CCT) had 2 high-quality (Level II, low RoB) studies showing improvements in pain scores, range of motion, and swelling, supporting its clinical use.
• Extracorporeal shockwave therapy (ESWT) was supported by 2 Level II studies; only one had low RoB, showing short-term benefits in patellar ligament thickness and PVF, but no long-term benefit on bone healing.
• Photobiomodulation (PBM) had mixed results across 3 Level II studies (all low RoB); only 1 showed positive impact on PVF, limiting its recommendation.
• Low-intensity pulsed ultrasound (LIPUS) showed no significant impact on gait analysis or bone healing in a Level II, low RoB study.
• Electrical muscle stimulation (EMS) improved lameness and thigh circumference in one Level III study, but had high-moderate RoB and involved experimentally-induced CCL rupture, limiting clinical relevance.
• No modality beyond exercise and CCT had consistent or strong evidence for efficacy in post-TPLO or extracapsular repair rehabilitation.
• The absence of standardized protocols, small sample sizes, and inconsistent outcome measures limited the generalizability of findings.

🔍 Key Findings

• Synovial CRP was significantly lower in osteoarthritis than both IMPA and bacterial infective arthritis (p=0.001 for both comparisons).
• Synovial CRP could not differentiate IMPA from bacterial infective arthritis (p=0.721), limiting its value as a stand-alone diagnostic test.
• Median synovial CRP concentrations were 0.2 mg/L (OA), 65.79 mg/L (IMPA), and 60.8 mg/L (infective arthritis).
• Synovial CRP is useful for distinguishing inflammatory from non-inflammatory arthropathies, but not infectious from sterile inflammatory disease.
• Synovial neutrophil count positively correlated with synovial CRP in IMPA and infective arthritis, supporting CRP as a marker of joint inflammation.
• Serum and synovial CRP showed a moderate positive correlation in IMPA cases (r=0.52), although not statistically significant.
• Higher synovial CRP was associated with increased lameness severity in osteoarthritis (r=0.91, p=0.004).
• Diagnosis of bacterial infective arthritis remains multifactorial, requiring integration of history, cytology, culture, and treatment response rather than CRP alone.